SOE 2023: Development of maculopathy after excessive caffeine and alcohol intake

Article

Paracentral acute middle maculopathy can develop after excessive intake of caffeine and alcohol according to Obadah Moushmoush, MD.

A refrigerated case of energy drinks at a grocery store. Image credit: ©Praneat – stock.adobe.com

Paracentral acute middle maculopathy can develop after excessive intake of caffeine and alcohol according to Obadah Moushmoush, MD. Image credit: ©Praneat – stock.adobe.com

Reviewed by Obadah Moushmoush, MD

Paracentral acute middle maculopathy can develop after excessive intake of caffeine and alcohol according to Obadah Moushmoush, MD, a resident at the Georgetown University, Washington DC. He reported the effects on the retina at the European Society of Ophthalmology Conference, Prague.

He described the case of a 49-year-old Caucasian man with no previous relevant medical history who presented to the retina clinic with the complaint of acute-onset blurred and distorted vision in the right eye.

The symptoms, which began 2 weeks before the patient presented, were described as looking through a dark storm cloud. The blurriness was localized to a specific spot in the right eye 20 degrees to the right of the central vision.

The examination revealed bilateral acuity levels of 20/15 and intraocular pressures of 17 mmHg; there was no afferent pupillary defect and a full range of extraocular muscle movement. The maculas and with no obvious retinopathy and the retinal peripheries were flat and attached. The optic nerve head and cup-to-disc ratio were unremarkable. Fundus photographs, fundus autofluorescence, fluorescein angiography images were normal.

Humphrey visual field evaluation showed a paracentral defect inferiorly. Optical coherence tomography images of the right eye showed thinning superiorly and distortion of the middle macula.

A diagnosis of paracentral acute middle maculopathy was established.

Upon further questioning, Dr. Moushmoush reported, the patient admitted to drinking about seven Red Bulls and vodka the night before the onset of symptoms.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.